MX2019007786A - Compuestos sustituidos de guanidina. - Google Patents
Compuestos sustituidos de guanidina.Info
- Publication number
- MX2019007786A MX2019007786A MX2019007786A MX2019007786A MX2019007786A MX 2019007786 A MX2019007786 A MX 2019007786A MX 2019007786 A MX2019007786 A MX 2019007786A MX 2019007786 A MX2019007786 A MX 2019007786A MX 2019007786 A MX2019007786 A MX 2019007786A
- Authority
- MX
- Mexico
- Prior art keywords
- guanidine compound
- substituted guanidine
- provides
- formula
- substituted
- Prior art date
Links
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 title 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N anhydrous guanidine Natural products NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 title 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 title 1
- -1 guanidine compound Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Abstract
La presente invencion provee un compuesto de formula general (I) (en donde X, es como se describe en la presente descripcion y las reivindicaciones), o una sal farmacologicamente aceptable del mismo, y una composicion farmaceutica que contiene ese compuesto. (Ver fórmula).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016255567 | 2016-12-28 | ||
| PCT/JP2017/046898 WO2018124179A1 (ja) | 2016-12-28 | 2017-12-27 | 置換グアニジン化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019007786A true MX2019007786A (es) | 2019-08-16 |
Family
ID=62709416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019007786A MX2019007786A (es) | 2016-12-28 | 2017-12-27 | Compuestos sustituidos de guanidina. |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US11396514B2 (es) |
| EP (1) | EP3564230B1 (es) |
| JP (1) | JP7103228B2 (es) |
| KR (1) | KR102607007B1 (es) |
| CN (1) | CN110114350B (es) |
| AU (1) | AU2017385291B2 (es) |
| BR (1) | BR112019012020A8 (es) |
| CA (1) | CA3048854A1 (es) |
| DK (1) | DK3564230T3 (es) |
| ES (1) | ES2909133T3 (es) |
| HR (1) | HRP20220383T1 (es) |
| HU (1) | HUE058181T2 (es) |
| LT (1) | LT3564230T (es) |
| MX (1) | MX2019007786A (es) |
| PL (1) | PL3564230T3 (es) |
| PT (1) | PT3564230T (es) |
| RS (1) | RS63103B1 (es) |
| RU (1) | RU2757279C2 (es) |
| SI (1) | SI3564230T1 (es) |
| WO (1) | WO2018124179A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112789277B (zh) * | 2018-10-22 | 2022-11-04 | 广东东阳光药业有限公司 | 胍类衍生物及其用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602005013793D1 (de) * | 2004-07-27 | 2009-05-20 | Astellas Pharma Inc | Thiazolderivate mit vap-1-hemmender wirkung |
| TWI490214B (zh) * | 2008-05-30 | 2015-07-01 | 艾德克 上野股份有限公司 | 苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途 |
| AU2010264720A1 (en) | 2009-06-24 | 2011-12-08 | Boehringer Ingelheim International Gmbh | New compounds, pharmaceutical composition and methods relating thereto |
| EP2479165B1 (en) | 2009-09-16 | 2017-10-25 | Astellas Pharma Inc. | Glycine compound |
| HUE028394T2 (en) * | 2011-03-15 | 2016-12-28 | Astellas Pharma Inc | Guanidin Compound |
| KR20180032576A (ko) | 2015-08-06 | 2018-03-30 | 우베 고산 가부시키가이샤 | 치환 구아니딘 유도체 |
-
2017
- 2017-12-27 LT LTEPPCT/JP2017/046898T patent/LT3564230T/lt unknown
- 2017-12-27 MX MX2019007786A patent/MX2019007786A/es unknown
- 2017-12-27 WO PCT/JP2017/046898 patent/WO2018124179A1/ja unknown
- 2017-12-27 SI SI201731125T patent/SI3564230T1/sl unknown
- 2017-12-27 EP EP17886109.2A patent/EP3564230B1/en active Active
- 2017-12-27 KR KR1020197021726A patent/KR102607007B1/ko active IP Right Grant
- 2017-12-27 HR HRP20220383TT patent/HRP20220383T1/hr unknown
- 2017-12-27 US US16/474,339 patent/US11396514B2/en active Active
- 2017-12-27 DK DK17886109.2T patent/DK3564230T3/da active
- 2017-12-27 AU AU2017385291A patent/AU2017385291B2/en active Active
- 2017-12-27 CN CN201780081296.6A patent/CN110114350B/zh active Active
- 2017-12-27 BR BR112019012020A patent/BR112019012020A8/pt active Search and Examination
- 2017-12-27 RS RS20220303A patent/RS63103B1/sr unknown
- 2017-12-27 RU RU2019123574A patent/RU2757279C2/ru active
- 2017-12-27 JP JP2018559577A patent/JP7103228B2/ja active Active
- 2017-12-27 CA CA3048854A patent/CA3048854A1/en active Pending
- 2017-12-27 ES ES17886109T patent/ES2909133T3/es active Active
- 2017-12-27 HU HUE17886109A patent/HUE058181T2/hu unknown
- 2017-12-27 PL PL17886109T patent/PL3564230T3/pl unknown
- 2017-12-27 PT PT178861092T patent/PT3564230T/pt unknown
-
2022
- 2022-06-16 US US17/841,815 patent/US11814393B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017385291B2 (en) | 2021-02-11 |
| CN110114350A (zh) | 2019-08-09 |
| EP3564230A1 (en) | 2019-11-06 |
| PT3564230T (pt) | 2022-05-19 |
| US11814393B2 (en) | 2023-11-14 |
| AU2017385291A1 (en) | 2019-07-18 |
| PL3564230T3 (pl) | 2022-05-09 |
| EP3564230B1 (en) | 2022-02-09 |
| RU2757279C2 (ru) | 2021-10-12 |
| US20220315599A1 (en) | 2022-10-06 |
| LT3564230T (lt) | 2022-04-11 |
| HRP20220383T1 (hr) | 2022-05-13 |
| KR102607007B1 (ko) | 2023-11-29 |
| US20190337962A1 (en) | 2019-11-07 |
| BR112019012020A2 (pt) | 2019-10-29 |
| RS63103B1 (sr) | 2022-04-29 |
| SI3564230T1 (sl) | 2022-05-31 |
| HUE058181T2 (hu) | 2022-07-28 |
| JP7103228B2 (ja) | 2022-07-20 |
| RU2019123574A3 (es) | 2021-03-25 |
| JPWO2018124179A1 (ja) | 2019-10-31 |
| CN110114350B (zh) | 2022-03-04 |
| DK3564230T3 (da) | 2022-03-28 |
| BR112019012020A8 (pt) | 2023-01-17 |
| US11396514B2 (en) | 2022-07-26 |
| RU2019123574A (ru) | 2021-01-29 |
| EP3564230A4 (en) | 2020-06-03 |
| CA3048854A1 (en) | 2018-07-05 |
| WO2018124179A1 (ja) | 2018-07-05 |
| KR20190097251A (ko) | 2019-08-20 |
| ES2909133T3 (es) | 2022-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016501813B1 (en) | 1,3-benzodioxole derivative | |
| SG11201804121RA (en) | Novel biphenyl compound or salt thereof | |
| NZ763551A (en) | Compounds useful for inhibiting cdk7 | |
| MX2018009459A (es) | Derivado de sulfonamida y composicion farmaceutica que contiene el mismo. | |
| MX2019014104A (es) | Compuesto novedoso de bifenilo o sal del mismo. | |
| PH12016500806A1 (en) | Urea derivative or pharmacologically acceptable salt thereof | |
| MX2017014035A (es) | Formas solidas novedosas. | |
| MY194116A (en) | Pharmaceutical compounds | |
| MX2018001517A (es) | Derivados sustituidos de guanidina. | |
| PH12017501539A1 (en) | Disacetoxytubulysin h and analogs thereof | |
| PH12019501178A1 (en) | Thiopene derivatives as antiviral agents | |
| PH12017501280B1 (en) | Hydroxyalkyl-piperazine derivatives as cxcr3 receptor modulators | |
| SA518390920B1 (ar) | مركبات فينوكسي أسيتاميد معالجة بإضافة حلقة | |
| MX2017016030A (es) | Derivado de dihidropirrolopirazol sustituido. | |
| PH12016500461A1 (en) | Polyethylene glycol-containing composition | |
| NZ731607A (en) | Dihydropyrimidin-2- one compounds and medical use thereof | |
| BR112018074985A2 (pt) | composições antibacterianas | |
| MX2017009292A (es) | Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3. | |
| MX2015016332A (es) | Inhibidores de alk biciclicos fusionados. | |
| AU2016351424A8 (en) | Pyranodipyridine compound | |
| MY193239A (en) | Novel b-lactamase inhibitors | |
| MX2015007309A (es) | Derivado de hidantoina. | |
| MX2019007786A (es) | Compuestos sustituidos de guanidina. | |
| EA201690908A1 (ru) | Пиразолопиримидиновые соединения | |
| MX2016013684A (es) | Composicion farmaceutica que contiene derivado de hidantoina. |